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Fevers associated  with  neoplastic  growth  occur commonly in  patients  with  acute 
leukemias (1), Hodgkin's disease (2), and other lymphomas (3), and less frequently in 
patients  with  carcinomas  such  as  hypernephromas  (4), hepatomas  (5),  or  tumors 
metastatic to the liver (6).  Since often no infectious agent can be implicated in such 
fevers, it is likely that many are caused by the malignant disease itself. Such tumor- 
associated  fevers,  like  fevers studied  in  animal  models,  presumably result  from the 
action of endogenous pyrogen (EP)  1, a small protein which is synthesized and released 
from leukocytes. When this protein enters the blood, it alters in some way the "set-point" 
of temperature-regulating neurons in the  hypothalamus,  inducing  responses of heat 
production and conservation, and thus causing fever in the host (7). Experiments to date 
have shown that EP is only produced by granulocytes, monocytes, or tissue macrophages. 
In addition, these cells require stimulation by inflammatory agents such as endotoxin or 
phagocytosis before EP production and release occurs. 
Fever associated with malignancies might be the result of EP production by 
neoplastic cells themselves. Alternatively, host mononuclear or polymorphonu- 
clear leukocytes may be stimulated to release EP by factors released by tumor 
cells, or generated by other host cells in response to tumor growth. In previous 
studies, abnormal, spontaneous EP production was demonstrated in cell suspen- 
sions prepared from spleen and lymph nodes of patients with Hodgkin's disease 
(8), but the cell type(s) responsible for this production were not identified.  We 
have now investigated release of EP by neoplastic cell lines in vitro, including 
six  mouse  tumor  lines  having  the  characteristics  of leukemia  or  lymphoma 
cells, three carcinoma lines of human origin, and one viral-transformed mouse 
fibroblast line.  Spontaneous EP release has been documented from five of the 
six mouse tumor cell lines. 
Materials  and  Methods 
All materials, glassware,  and reagents were obtained  or made sterile and pyrogen-free by 
methods described previously  (9). All test supernates were centrifuged at 800-2,000 g for 10-15 
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from the National Institute of Allergy and Infectious Diseases. 
1  Abbreviations  used in this paper:  BCG, bacillus Calmette-Gu~rin; CSA, colony-stimulating 
activity; EP, endogenous pyrogen; LAF, lymphocyte-activating  factor; LPS, lipopolysaccharide; 
MEM, Eagle's minimal essential medium; PF, pyrogen-free. 
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min  and  cultured  in  thioglycollate  broth  before  injection;  any  contaminated  samples  were 
discarded. 
Pyrogen  Assay.  Culture  supernates  were  tested  for  pyrogenicity  using  a  mouse  bioassay 
which  has  been  described  previously  (10,  11).  Briefly,  7-8-wk-old  Swiss-Webster  mice  (Yale 
colony) were  kept at 35°C  for 1-2 h  until stable temperatures were  achieved.  They  were then 
injected  intravenously  with  0.3  ml  of  a  test  solution,  usually  a  dilution  of superuate  from 
incubated cells,  and rectal temperatures were  monitored every  10  min for 50  min.  Maximum 
temperature changes from baseline 20 rain after injection were used to determine the pyrogen 
content of the sample. 
Tissue Culture  Cell Lines.  All cell  lines were  maintained in  75  cm  2 plastic flasks  (Falcon 
Plastics, Div. BioQuest, Oxnard,  Calif.), and incubated in 5% CO2,  95% air. Fresh medium was 
supplied every 2-3 days; for mouse tumor cell lines, only one-half the volume of supernate was 
replaced with fresh medium at each time interval. 
Mouse tumor cell lines (J-774, PU5-1.8, WEHI-3, P388 D1, RAW-8, and R-8) were obtained from 
Dr. Peter Ralph, Walker Laboratory, Sloane-Kettering Institute for Cancer Research, Rye, N. Y. 
The characteristics and origins of these cells have been described previously (12-16).  Briefly, J 
774,  PU5-1.8, and P388 D1 cells resemble macrophages or histiocytes; WEHI is a  myelomonocytic 
leukemia  cell  line;  RAW-8  and  R-8 cells  were  derived  from  mouse  lymphomas  and  resemble 
lymphocytes. Cells were maintained in RPMI-1640 medium (Grand Island Biological Co., Grand 
Island, N.Y.)  with 10% heat-inactivated, filtered fetal calf serum, 50 U  penicillin/ml and 50 ~g 
streptomycin/ml. For cell transfer,  ---- 2 ml of supernate containing ~  104 cells were transferred 
weekly to new incubation flasks with 30 ml fresh medium.  Before transfer of J-774, PUS-1.8, or 
WEHI-3  cells,  which grow  as  loosely  adherent cell  layers,  cells were  detached from the flask 
surface by vigorous pipetting. 
For experiments with the histiocytic and myelomonocytic cell lines, flasks of a single line with 
nearly  confluent,  adherent  cell  layers  were  selected,  usually  3-4  days  after  seeding.  All 
supernatant  medium  was  discarded,  and  flasks  were  rinsed  four  times  with  RPMI  (without 
serum) warmed to 37°C.  10 ml RPMI with 2.5 mg/ml lactalbumin hydrolysate (ICN Nutritional 
Biochemicals, Div. International Chemical & Nuclear Corp., Cleveland, Ohio), pyrogen-free (PF) 
medium, were then added. In some experiments, 10% endotoxin free, heat-inactivated fetal bovine 
serum (Flow Laboratories, Inc., Rockville, Md.; lot 4055 1190) was used in place of lactalbumin. In 
other experiments, heat-killed staphylococci, prepared as described previously (11), were added to 
one of a pair of flasks at an estimated ratio of 10:1 bacteria to cells. The flasks were incubated for 
18 or 42 h. For experiments with R-8 and RAW-8 cells which grow in suspension, 3-4 days after 
seeding the flask contents were removed, centrifuged at 100 g  for 10 min, and the supernatant 
medium was discarded. The cells were resuspended in RPMI without serum, centrifuged at 100 g 
for 10 min, and this washing procedure was repeated three times. Cells were finally suspended in 
10 ml PF medium and equal aliquots were incubated in new flasks for 18 or 42 h. 
Human tumor cell lines (Caki-1, Caki-2, and SK-HEP-1) were obtained from Dr. JSrgen Fogh, 
also of Walker Laboratory.  The characteristics and origins of these lines have been previously 
reported (17).  Caki-1 and Caki-2 cells, derived from clear cell renal adenocarcinomas, were grown 
in McCoy's 5 A medium (modified) (Grand Island Biological Co.), containing 15% filtered fetal calf 
serum,  50  U  penicillin/ml,  and  50  /~g  streptomycin/ml.  SK-HEP-1  cells,  derived  from  an 
adenocarcinoma of the liver,  were similarly maintained except that Eagle's minimal essential 
medium (MEM; Aute-POW,  Flow Laboratories, Inc.) plus 2 mM L-glutamine was substituted for 
McCoy's medium.  For  transfer of cells,  flasks with confluent layers were  either treated  with 
Viokase (11) (Grand Island Biological Co.) for Caki-1 and SK-HEP-1 lines, or cells were detached 
by scraping with a  rubber policeman, for Caki-2 cells. One half of the cells recovered from each 
flask were transferred to new flasks containing 20 ml of the appropriate medium. 
For experiments with human tumor cell lines, all supernate was removed from flasks with 
confluent cell layers,  and the cells were rinsed three times with medium containing no serum. 
Flasks were then reincubated for 18 to 42 h  with 5 ml of medium containing 15% pooled normal 
human serum. 5 ml medium with 15% human serum was also incubated as a control. 
3T3-SV 40 mouse fibroblasts (Swiss-Webster origin) were obtained from B.  Dorman,  Depart- 
ment of Biology, and Dr.  Paul Lebowitz,  Department of Medicine, Yale University. Cells were 
grown in MEM (see above) with 2 mM L-glutamine, 10% fetal calf serum, 50 U penicillin, and 50 
~tg streptomycin/ml. Once a  week, cells were transferred using Viokase as described above. For PHYLLIS  BODEL  1505 
experiments, the same techniques were used for rinsing  and incubating cell  layers  as those 
described  for  human tumor cell  lines,  except  that  10% rather  than 15% serum was used. 
At  the  end  of  all  incubations,  supernates  were  removed, centrifuged  at  800  or  2000g  for  20  rain, 
and  assayed  for  pyrogen  content.  Cells  were  also  removed  and  counted,  using  a  hemocytometer or 
Coulter  counter  (model ZF;  Coulter  Electronics  Inc.,  Hialeah,  Fla.),  and  viability  was  measured  in 
most  experiments by  exclusion  of  1%  eosin  dye.  When present,  nonadherent  cells  were  collected  by 
initial  centrifugation  of  the supernates  at 100  g; adherent cells  were obtained  by scraping  or  by 
treatment with Viokase. For cells  incubated with  Streptomyces  albus,  percent  phagocytosis  was 
estimated  from Wright's-stained  coverslip  smears.  This  varied  from  59-77% in  all  experiments. 
Heat  and  Pronase  Treatment  of  Pyrogens.  50  mg of  pronase  (B-grade;  Calbiochem, San Diego, 
Calif.)  was dissolved  in  5 ml saline,  and preincubated  for  2 h at  37°C.  0.05  ml was then added to 
2.5  ml  of  a pyrogenic  supernate  and  the  mixture was incubated  for  4  h at  37°C.  Another 2.5  ml of 
the  pyrogenic  supernate was incubated  for  3 h at  37°C,  and  then  for  1  h at  56°C.  A third  aliquot 
was incubated for 4 h at 37°C with no additions.  As a control,  2.5 ml tissue  culture  medium 
containing  no pyrogen, with  0.05  ml pronase added, was also  incubated  at  37°C for  4 h. 
Assays for lntracellular  Pyrogen.  Flasks  of J-774  cells were  chosen  3  or  4  days  after cell 
transfer, and cells were incubated in PF medium for 18 or 42 h, as described above. Supernatant 
medium was removed for subsequent pyrogen assay, and cell layers were rinsed three times with 
warmed RPMI medium. 5 ml RPMI was then added to the flask, and the cells were detached with 
a  rubber policeman.  In some  experiments,  this cell suspension was transferred to  a  duplicate 
flask and additional cells were collected. Cell numbers in the suspensions, both total and percent 
viable, were determined as described above. The mixture was disrupted by five cycles of freeze- 
thawing in dry ice-acetone, centrifuged at 2,000 g for 20 rain, and the supernate was then assayed 
for pyrogen content. 
Sephadex Filtration  ofPyrogenic Supernates.  PF medium was added to flasks of J-774 cells as 
described previously, and after a  48-h incubation, it was removed and stored at -20"C. A pool of 
100 ml medium was assayed for pyrogen content and then concentrated to 2.5 ml by evaporation 
through dialysis tubing in  front of a  fan.  This  material  was  filtered through a  48  x  2.5-cm 
Sephadex G-75 column, prepared as described previously (18) and equilibrated with phosphate- 
buffered saline, p H 7.4, containing 2.5 mg/ml lactalbumin hydrolysate. Sodium azide was omitted. 
5-ml  effluent fractions were  collected,  and  0.3-ml  vol were  injected for pyrogen  assay.  Three 
experiments with J-774 pyrogen were carried out, using two different columns. Human monocyte 
pyrogen was also prepared as described previously (18), and 1.5 ml containing four rabbit doses 
was filtered separately on one of the columns.  Where pyrogen assays of individual tubes were 
carried out at several dilutions, a "derived" (AT) was calculated by taking the average values for 
peak AT and multiplying by the dilution. Markers to determine exclusion and filtration volumes 
for  different  molecular  weights  included  blue  dextran,  ovalbumin  (Worthington Biochemical 
Corp.,  Freehold,  N.  J.),  and  2  x  crystallized  trypsin  and  ribonuelease  A  (both  from  ICN 
Nutritional Biochemicals). Protein markers were applied singly to each column after completion 
of the pyrogen studies using buffer containing no lactalbumin, and their filtration volumes were 
determined by measurement of optical density at 290  h. 
Results 
Histiocytic  and Myelomonocytic Tumor Cell Lines.  Supernate  from tissue 
culture flasks was obtained 24 or 48 h after incubation of  the cells  in PF culture 
media, and was tested in mice for pyrogenicity. The results of  a representative 
experiment  with J-774  cells are  shown  in Fig.  1. Although  the  supernate 
removed  after 24 h  of incubation was  only equivocally pyrogenic,  supernate 
from the 48-h incubation clearly produced a febrile response in mice. The shape 
of  the fever curve, which peaked at 20 rain after injection and rapidly returned 
to  baseline  or below,  is identical  to that  produced  by  injection  of mouse 
rnacrophage pyrogen,  obtained after stimulation of normal peritoneal macro- 
phages by phagocytosis  (10, 11). Injection of media alone (control) caused no 
elevation of temperature,  When  results of a series of  experiments were exam- 1506  PYROGEN  PRODUCTION  BY  TUMOR  CELL  LINES  IN  VITRO 
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FZG.  1.  Spontaneous  pyrogen  release by  histiocytic tumor  cells  (J-774)  during  in  vitro 
incubation.  Average temperature change (AT) from baseline in groups of 11-12 mice after 
injection of culture supernates from 24-h ([])  and 48-h (O) incubations of cells, or control 
media  (A), is shown. Each supernatant  sample was derived from  1-5  ×  105 viable cells. 
SEM at 20 min are shown by brackets. 
ined,  pyrogen was  clearly detectable  in  medium from 24-h  incubations,  but 
larger amounts were always present  after 48-h  incubations. In addition, the 
same results were obtained when PF media contained fetal bovine serum in 
place  of lactalbumin.  These  results  suggest  that  J-774  cells  spontaneously 
release pyrogen into the medium during in vitro culture. 
Similar experiments were carried out with three other mouse cell lines: PU5- 
1.8  and  P  388  D1,  which have  the  characteristics of histiocytic tumors,  and 
WEHI-3,  previously  characterized  as  a  myelomonocytic leukemia.  In  each 
instance,  we  obtained findings which were  essentially identical to those  de- 
scribed  above for J-774  cells.  A  summary of our results  is  shown  in  Fig.  2. 
Pyrogen was present in supernates of 48-h incubations of all four cell lines• We 
initially tested the culture supernates in a wide range of doses, injecting media 
derived from 5  x  10L10  s viable cells (complete data not shown). Since subse- 
quent studies showed that maximal temperature elevations in the mice occurred 
regularly when media representing about 1-5  ×  105 cells per dose was injected, 
this dilution of supernate was then tested most extensively for each cell line. 
Lymphocytic  Tumor  Cell  Lines•  Spontaneous  pyrogen  release  during  in 
vitro culture was demonstrated in similar experiments using cells from one of 
two mouse cell lines previously characterized as closely resembling lymphocytic 
lymphoma cells (Fig. 3). Unlike the results with the macrophage lines discussed 
above,  pyrogen in  the  PF  culture  medium of RAW-8  cells  was  more  easily 
detectable after 24 h than after 48 h incubation• However, maximal fevers were 
produced as before by dosages of supernate corresponding to  1-5  ×  105  cells/ 
dose. We were unable to demonstrate any pyrogen release at either 24 or 48 h 
into PF  media by the  other  lymphocytic tumor line,  R-8,  although doses  of 
supernate corresponding to 10L10  s viable cells were examined. 
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FIG.  2.  Spontaneous pyrogen release by cells from three histiocytic tumor cell lines (J 
774,  P-388  D1,  PU5-1.8)  and  one  myelomonocytic leukemia  line  (WEHI-3).  In this  and 
subsequent figures,  average maximum temperature elevation (AT)  _+ SEM,  20 rain after 
injection of culture supernates into groups of mice, is shown by the height of the bars, and 
numbers of mice in parentheses. Cells/dose, shown below the bars, indicates the number of 
viable ceils recovered after incubation from which that dose of supernate was derived. In 
this experiment, cells were incubated in PF media for 48 h, and the supernate was diluted 
as needed and injected for assay. Control injections were of media incubated without cells. 
Cells.  We studied the effect ofphagocytosis of staphylococci on pyrogen release 
by two histocytic cell lines, J-774 and PU5-1.8. In both cases, we noted increased 
fevers  in  the  mice  after  injection  of  supernates  from  cells  stimulated  by 
ingestion of bacteria compared to the same numbers of cells releasing pyrogen 
spontaneously in culture (Fig. 4). Although the mouse assay for pyrogen is not 
quantitative  over a  large dose range,  it is roughly quantitative  over a  two- to 
three-fold range  between minimal  and maximal  temperature  elevation,  when 
increasing  amounts  of pyrogen  are  injected  (10).  These  results,  therefore, 
suggest  that  there  were  small,  probably  one-  to  twofold,  increases  in  the 
amounts of pyrogen released by these cells after particle ingestion.  We did not 
study either  of the  lymphocyte-like lines  after  incubation  with  staphylococci 
since we presumed they were nonphagocytic;  R  8 cells do not ingest bacillus 
Calmette-Gu~rin  (BCG) (19). 1508  PYROGEN  PRODUCTION  BY  TUMOR  CELL  LINES  IN  VITRO 
e-. 
E 
O 
A 
O 
I- 
<3 
.4 
.3 
.I 
0 
-.I 
(9) 
I 
(2E  (ll)  (20) 
U 
RAW-  8 
.2  - 
.I  - 
o 
5x 10  4 -  10 5 
R-8 
(11)  (11)  (8) 
10 5 -  5xlO 5  5xlO 5  -  10  6  CONTROL 
CELLS/DOSE 
FIG.  3.  Spontaneous pyrogen release by one of two lines of mouse lymphocytic-type  tumor 
cells (RAW-8, R-8) during in vitro culture. Cells were incubated in PF media for 24 h before 
supernate was assayed. See Fig. 2 for other details. 
Characteristics of Tumor Cell Pyrogens.  As is illustrated in Fig. 1, the type 
of febrile response induced by the pyrogens from all five of these cell lines was 
identical  to  that  produced  in  mice  by  normal  leukocyte  EP  (10, 20). The 
pyrogens in flask supernates of the  mouse tumor cells appeared to be  more 
stable  than those  present  in  crude  supernates  of stimulated mouse  macro- 
phages, since they lost little activity during storage at -20°C for 1 wk, or -70°C 
for over 3 wk, whereas mouse macrophage pyrogen loses activity within days at 
4°C and within 1 wk at -70°C (unpublished observations). However, the tumor 
cell pyrogens were inactivated by heating to 56°C for 1 h, and by incubation 
with pronase (Fig. 5). These characteristics suggest that they are proteins, like 
other endogenous pyrogens of leukocyte origin (7). 
We obtained an estimate of the molecular weight of the pyrogen released by 
J-774 cells by filtration of  a concentrate of  culture supernate through a Sephadex 
G-75 column (Fig. 6).  Two peaks of pyrogenic activity were present,  one at a 
mol wt of =  30,000,  and the other at a  mol wt ___60,000, close to the exclusion 
volume  of the  column.  Because  the  pyrogen  assay  in  mice  is  not  easy  to PHYLLIS  BODEL  1509 
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FIG. 4.  Comparison of  spontaneous pyrogen release  by cells  from two histiocytic  tumor 
cell  lines  (PU5-1.8 and J-774)  with that induced by phagocytosis of  heat-killed  staphylo- 
cocci.  Cells  were incubated in PF media for 48 h after  addition of  bacteria  or an equal 
volume of  saline.  The number of  cells  containing bacteria  was estimated  to  be between 59 
and 77% in all experiments. P  values were calculated  using Student's t test  for small 
samples. See Fig. 2 for  other details. 
quantitate, it is not certain how much of the total  pyrogenic activity was 
associated with each peak. However, the amounts appeared to be similar. By 
contrast, when supernate from human  monocytes was applied to the same 
column, the two expected peaks of  activity  were noted, at mol wt of ~  14,000 
and 40,000,  and the quantity of  the 14,000  tool  wt pyrogenic species  was clearly 
greater, as reported previously (18). 
Mechanism of Production of Tumor Cell  Pyrogen.  We  have done some 
preliminary studies to examine the mode of  production of  pyrogens by mouse 
tumor cells.  When  flasks containing J-774 or RAW-8  cells  in PF media were 
placed at 4°C, supernates remained PF, in contrast to supernates of parallel 
flasks  incubated as usual at  37°C.  In addition,  more pyrogen appeared in flasks 
of  histocytic  and myelomonocytic tumor cells  as incubation continued for  48-72 
h. Although we usually chose flasks containing moderate to large numbers of 
cells  at 3, 4, or 5 days after  seeding, pyrogen production appeared to progress 
during continued incubation regardless of  the initial  age of  the culture. When 
rinsed cell  layers were disrupted by freeze-thawing, and the resulting super- 1510  PYROGEN  PRODUCTION  BY  TUMOR  CELL  LINES  IN  VITRO 
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FIG.  5.  Inactivation  of  pyrogenic supernates (EP) from two mouse histiocytic  tumor cell 
lines  (PU5-1.8 and J-774)  by incubation with pronase or  by heating for  I h at 56°C. See text 
for  details. 
nates were assayed for progen content, at no time were significant amounts of 
intracellular pyrogen detected  (Table I), even though pyrogen was present in 
the culture supernates of the same cells (positive assay results are underlined). 
The character of the PF medium in which cells were cultured to collect pyrogen 
for  assay  did  not  appear  to  affect  pyrogen  production,  since  we  obtained 
identical results using medium containing either lactalbumin hydrolysate or a 
PF bovine serum. These findings, therefore, suggest that active production and 
secretion of pyrogen by these cells is occurring spontaneously and continuously 
during in vitro culture. 
Comparison  of Pyrogen  Production  with  Other  Characteristics  of Mouse 
Tumor Cell Lines.  As shown in Table II, pyrogen was produced by all tumor 
cell  lines  which possessed properties of  macrophages, including the capacity for 
phagocytosis of  bacterial particles  or zymosan, presence of  IgG receptors on the 
cell  surface,  and secretion  of  lysozyme. Although RAW-8 cells  resemble lympho- 
cytes morphologically, they secrete lysozyme in culture, and therefore presum- 
ably contain cells  with macrophage characteristics (16).  The cell  line  R-8 has 
not to date been reported  to have  any macrophage  characteristics, and is 
presumably  composed  of lymphocyte-derived  cells;  cells of this line did not 
produce pyrogen. PHYLLIS  BODEL  1511 
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FIO.  6.  Sephadex  G-75 filtration  of pyrogenic  supernates  from J-774 cells and  stimulated 
human  blood  monocytes.  5-ml  fractions  were  collected  and  0.3-ml  samples  (undiluted  or 
diluted  1:2-1:8) were  injected into  mice for pyrogen  assay.  Derived  change  in temperature 
(AT)  was  calculated  as  described  in  Materials  and  Methods.  Each  point  represents  the 
average  temperature  responses  of 4-9 mice.  Peak  elution  volumes  of marker  proteins  are 
indicated  by arrows. 
17o 
TABLE I 
Differences in Intra- and Extracellular  Pyrogen from J-774  Cells Incubated  for Either 
18 or 42 h* 
Cells x  104/doses 
Cell incubation  Controls§ 
5-10  11-49  49-100 
Supernate  of  dis- 
rupted cells 
Culture supernate 
h 
18  0.02 ±  .07 (6~I  -0.04± .05 (8)  -0.01 ±  .06(7) 
42  -0.01 ±  .05 (7)  0.00± .05 (15)  -0.10 ±  .03 (11) 
18  ND¶  0.1ffif8± .04(10)  ND 
42  ND  ~?,~± .03 (23)  ND 
-0.11 ±  .03(32) 
* Average change in temperature from baseline 20 min aRer injection, ± SEM. 
$ Cells from which supernate was derived for injection. 
§ Injection of medium alone. 
II Number of injections. 
¶ ND, not determined. 
Studies  of Pyrogen  Release  by Human  Carcinoma  Tumor  Cell Lines  and 
Viral-Transformed Mouse Fibroblasts.  Since patients with tumors other than 
leukemias  and  lymphomas  occasionally  suffer  from  prolonged,  unexplained 
fevers, we also studied the capacity for pyrogen production by cells from three 
tumor  cell  lines  derived  from  human  carcinomas,  two renal  cell  carcinomas 
(CAKI-1 and CAKI-2),  and one hepatoma  (SK-HEP-1).  In addition,  we tested 1512  PYROGEN  PRODUCTION  BY  TUMOR  CELL  LINES  IN  VITRO 
TABLE  II 
Mouse Tumor Cell Lines 
Cell line 
LAF se-  Pyregen secretion 
Morphologic and  Functional proper.  Lysozyme  cretion 
Origin  growth characteris-  ARer 
tics  ties  secretion  (LPS  Sponta-  phagocy- 
added)  neotm 
tosis 
J774 
PU5-1.8 
P388D1 
WEHI-3 
RAW8 
R8 
Balb/c  derived  from  Well-differentiated 
reticulum  cell  sar-  histiocytic  lyre. 
coma,  ascitos  form  phoma;  loosely  ed- 
(13,  19)  herent (21) 
Balblc  derived  from  Histiocytic,  loosely 
lymphoma  PU  5-1,  adherent 
asoites form (16) 
DBAJ2  derived  from  Histiocytic,  loosely 
methylcholan-  adherent 
threne-induced 
lymphoid  tumor, as- 
cites  form (12) 
Balb/c cloned from a  Monocytic, Ib~sely  ad- 
myelomonocytic  herent,  differen- 
leukemia (14)  tiates  into  granulo- 
cytic  and monocytic 
colonies  (22) 
Balb/c  derived  from  Lymphocytic;  nonad- 
Abelsen  leukemia  herent 
virus-induced  lym- 
phoma (15,  23) 
Balb/c  x  C  57 BL/6 
derived from Abel- 
son  virus-induced 
lymphoearcoma,  "B" 
lymphoma (15) 
Phagocytic:  BCG,  + +  + +  + +  + + + 
zymosan, latex, ab-  (16,  19)  (24) 
coated  erythre- 
cytes,  staph;  ab-de- 
pendent target cell 
lysis  (19,  21) 
Phagocytic:  BCG,  + +  +  +  + + 
zymosan,  latex,  (16,  19)  (24) 
staph;  produces 
CSA after  LPS (25) 
Phagocytic: BCG, la-  + +  + +  + +  ND 
tex,  zymosan,  (16)  (24) 
staph;  surface  Ca 
and Fc IgG recep- 
tors; "Nonspecific" 
esterase  +;  lyses 
ab-coated  erythro- 
cytes (12,  19) 
Phagocytic:  BCG,  +  +  + +  ND 
zymosan,  latex;  (19)  (24) 
produces  CSA  (19, 
22) 
+  ND*  +  ND 
(16) 
Lymphocytic;  nonad-  Not  phagocytic  for  -  ND  ND 
herent  BCG (19)  (16) 
* ND, not determined. 
the hypothesis that viral transformation might confer the potential for pyrogen 
production  on  a  mouse  fibroblast  cell  line  previously  shown  not  to  produce 
pyrogen  spontaneously  (11).  We  therefore  tested  incubation  media  obtained 
after 18- and 42-h incubations from the three human carcinoma cell lines, and 
after  18-h  incubations  from  3T3-SV  40  transformed  mouse  fibroblasts.  We 
injected dosages of supernate derived from 0.5-49  x  104 cells for CAKI-1  and -2 
lines; 1->50  ×  104 cells for the SK-HEP-1  cells, and 5->100  ×  104 cells for the 
mouse fibroblasts. 6-20 mice were used for each assay.  In no instance were we 
able  to  demonstrate  spontaneous  pyrogen  release  by  any  of these  cell lines. 
Although  the  carcinoma  cell  lines  were  of human  origin,  we  have  shown 
elsewhere (20) that pyrogen released by human leukocytes is easily detectable 
in mice. 
Discussion 
Unexplained  fevers  occur  commonly  in  diseases  such  as  acute  leukemias, 
Hodgkin's disease, and other lymphomas (1-3), most of which are characterized 
by proliferation of phagocytic cells of bone marrow origin,  including granulo- 
cytes,  monocytes,  and macrophages or histiocytes.  Normal cells of these types PHYLLIS  BODEL  1513 
produce  pyrogen  only  af~er  stimulation  with  an  exogenous  agent,  such  as 
endotoxin or phagocytosis, and production of pyrogen ceases after 1-2 days (7). 
In the studies reported here, we have demonstrated that three mouse tumor cell 
lines with characteristics of macrophage or histiocytic tumors,  and one identi- 
fied as a  myelomonocytic leukemia,  release pyrogen during  in vitro culture. 
Moreover, this release appears to occur spontaneously and continuously during 
cell  growth  and  multiplication.  This  conclusion  is  supported  by  our  data 
showing that increasing amounts of pyrogen relative to cell numbers appear in 
the culture media with time, that similar amounts of pyrogen are produced by 
cells chosen either 3, 4, or 5 days after seeding, and that pyrogen accumulates 
in culture  media which is identical  to standard  growth  media except for the 
absence  of endotoxin.  Thus,  these  tumor  cells  appear  to  have  retained  the 
capability to produce pyrogen that is characteristic of their nonmalignant  cells 
of origin, but to have acquired an altered mechanism for production of pyrogen, 
since they apparently require no initiating  stimulus,  and production does not 
cease after 24-48 h. 
In preliminary studies, we have determined that production and secretion of 
the tumor cell pyrogens is an active, energy-requiring process. Cells kept at 4°C 
failed to release pyrogen. At no time were we able to detect significant levels of 
intracellular  pyrogen in the one cell line examined,  even though pyrogen was 
present in increasing amounts in the extracellular medium.  Small but signifi- 
cant increases in pyrogen production occurred after incubation of cells from two 
histiocytic tumor lines with staphylococci, during which time most cells ingested 
bacteria.  These  results  are  similar  to  those  obtained  in  studies  of pyrogen 
synthesis  and  release  by normal  granulocytes  and  monocytes  (7),  indicating 
that  the  tumor  cells  retain  some  of the  properties  associated  with  pyrogen 
production  of their  cells  of origin.  On the  other hand,  as  noted  above,  they 
appear  to  have  lost  at  least  a  part  of the  normal  control  mechanisms  for 
initiation and cessation of transcription of the pyrogen molecule, presumably a 
gene-mediated function (26,  27). 
The  pyrogens  released  by  these  tumor  cell  lines  appear  similar  to  the 
endogenous pyrogens that are produced when normal phagocytic cells of bone 
marrow origin are stimulated  by phagocytosis or other inflammatory  agents. 
Pyrogen  produced  by the  macrephage  tumor  lines  J-774  and  PU5-1.8  were 
inactivated by heating at 56°C for 1 h and by a 4-h incubation with pronase. All 
pyrogens produced febrile responses characteristic of EP in mice, as illustrated 
in  Fig.  1.  These  properties  are  the  same  as  those  of endogenous  pyrogens 
derived from normal  human  (20),  rabbit  (P.  Bodel, unpublished observations) 
and  mouse  (10)  granulocytes,  monocytes,  or  macrophages.  The  estimated 
molecular weights of pyrogens produced by J-774 cells were,  however,  larger 
than  those  reported  for  all  other  endogenous  pyrogens  previously  studied, 
including  those  produced  by  granulocytes,  monocytes,  and  macrophages  of 
human or rabbit origin (18,  28-30).  We have not yet determined the molecular 
weight of mouse macrophage  pyrogen because of the lability of the molecule; 
possibly, pyrogens from mouse leukocytes will also prove to be of unusual size. 
Alternatively, pyrogenic molecules produced by tumor cells may have different 
physico-chemical characteristics from pyrogens produced by their nonmalignant 
cells of origin. 1514  PYROGEN  PRODUCTION  BY  TUMOR  CELL  LINES  IN  VITRO 
When tumor lines of carcinomas or viral-transformed fibroblasts were stud- 
ied, we failed to detect any pyrogen in culture supernates. Thus, although many 
carcinomas are associated with unexplained fever in occasional patients,  our 
studies do not provide support  for the hypothesis that  such tumor cells can 
produce pyrogen. These data extend our previous observations that HeLa cells 
and fibroblasts did not produce pyrogen, even after ingestion of particles (11). 
Possibly, fever in patients that is associated with the growth of carcinomas is a 
result of host cell interactions with the tumor, producing stimulation of host 
granulocytes, monocytes, or macrophages to produce pyrogen, rather than the 
result of the release of pyrogen by the tumor cells themselves. 
The same cell lines that released pyrogen in our studies have been shown by 
others to secrete lysozyme, and in all but one instance (RAW-8), to have other 
macrophage characteristics, detailed in Table II. Two of the cell lines produce 
colony-stimulating activity (CSA), either spontaneously (19), or after addition 
of  agents  such  as  lipopolysaccharide  (LPS)  or  zymosan  (25). Lymphocyte- 
activating factor (LAF) is produced by all four macrophage tumor cell lines, 
after stimulation by LPS (24). It is noteworthy that tumor cells of presumed B- 
lymphocyte origin (R-8) did not produce pyrogen in our experiments. Normal 
lymphocytes have never been found to produce pyrogen, even after antigenic or 
blastogenic stimulation (7). 
Our results raise the possibility that tumor-associated fever in patients with 
certain malignancies, such as some acute leukemias and lymphomas, may be 
due to the production of endogenous pyrogen by the malignant cells of granulo- 
cytic or monocytic origin. By extrapolation from studies of the cell lines WEHI- 
3 and RAW-8,  it seems likely that the pyrogen molecules can be produced by 
immature cells at a stage of maturation preceding differentiation into granulo- 
cytes or monocytes. The hypothesis that malignant granulocytes and macro- 
phages release pyrogen spontaneously during growth would be consistent with 
the  observation  that  tumor-associated  fever  occurs  in  patients  with  these 
diseases during relapse, or at times of disease activity, but not during remis- 
sions  (1-3).  Preliminary studies have also shown that the human histiocytic 
tumor cell line,  U-937  (16), also releases pyrogen during in vitro culture (P. 
Bodel  and  P.  Ralph,  unpublished  observations).  Such cells  may provide  an 
easily available source of human EP for laboratory investigations. 
Summary 
Tumor-associated fever occurs commonly in acute leukemias and lymphomas. 
We investigated the capacity for in vitro production of pyrogen by three mouse 
histiocytic lymphoma cell lines (J-774, PU5-1.8, p 388 D1), one myelomonocytic 
line (WEHI-3), and two lymphoma-derived lines, RAW-8 and R-8. Pyrogen was 
released spontaneously into the culture medium during growth by all cell lines 
with macrophage or myeloid characteristics including lysozyme production; R-8 
cells, of presumed B-lymphocyte origin, did not produce pyrogen. When injected 
into mice, the pyrogens gave fever curves typical of endogenous pyrogen, were 
inactivated by heating to 56°C and by pronase digestion,  and appeared to be 
secreted continuously by viable cells. Two pyrogenic molecular species produced 
by J-774 cells were identified by Sephadex filtration, one of mol wt ~  30,000, PHYLLIS  BODEL  1515 
and the other ___60,000. By contrast, three carcinoma cell lines of human origin 
and SV-40 3T3 mouse fibroblasts did not produce pyrogen in vitro. These results 
suggest that some malignant cells derived from phagocytic cells of bone marrow 
origin  retain  their  capacity  for  pyrogen  production,  and  may  spontaneously 
secrete pyrogen during growth. 
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